# Four Corners Property Trust, Inc.: financial statements, quarterly

FCPT · NYSE · CIK 1650132 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/fcpt.md) · [Financials](/companies/fcpt/financials.md) · [Filings](/companies/fcpt/filings.md) · [Insiders](/companies/fcpt/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/fcpt/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [7.5 d](/filings/0001193125-26-048898.md) | [7.9](/filings/0000950170-25-061874.md) | [7.9](/filings/0000950170-25-100336.md) | [7.5](/filings/0001193125-25-256338.md) | [7.6 d](/filings/0001193125-26-048898.md) | [8.0](/filings/0001193125-26-197581.md) | [8.0](/filings/0001193125-26-326216.md) | [7.6](/filings/0001193125-26-437877.md) | [7.8 d](/filings/0001193125-26-048898.md) | [8.4](/filings/0001193125-26-197581.md) | [8.4](/filings/0001193125-26-326216.md) | [8.0](/filings/0001193125-26-437877.md) |
| Operating income | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $m | [12.4 d](/filings/0001193125-26-048898.md) | [12.3](/filings/0000950170-25-061874.md) | [12.3](/filings/0000950170-25-100336.md) | [12.3](/filings/0001193125-25-256338.md) | [12.3 d](/filings/0001193125-26-048898.md) | [12.7](/filings/0001193125-26-197581.md) | [13.1](/filings/0001193125-26-326216.md) | [13.0](/filings/0001193125-26-437877.md) | [13.1 d](/filings/0001193125-26-048898.md) | [13.1](/filings/0001193125-26-197581.md) | [13.8](/filings/0001193125-26-326216.md) | [17.4](/filings/0001193125-26-437877.md) |
| Income tax | $m | [0.1 d](/filings/0001193125-26-048898.md) | [0.0](/filings/0000950170-25-061874.md) | [0.1](/filings/0000950170-25-100336.md) | [0.1](/filings/0001193125-25-256338.md) | [0.1 d](/filings/0001193125-26-048898.md) | [0.1](/filings/0001193125-26-197581.md) | [0.1](/filings/0001193125-26-326216.md) | [0.0](/filings/0001193125-26-437877.md) | [0.1 d](/filings/0001193125-26-048898.md) | [0.1](/filings/0001193125-26-197581.md) | [0.1](/filings/0001193125-26-326216.md) | [0.5](/filings/0001193125-26-437877.md) |
| Net income | $m | [24.4 d](/filings/0001193125-26-048898.md) | [24.0](/filings/0000950170-25-061874.md) | [24.7](/filings/0000950170-25-100336.md) | [25.6](/filings/0001193125-25-256338.md) | [26.2 d](/filings/0001193125-26-048898.md) | [26.2](/filings/0001193125-26-197581.md) | [27.9](/filings/0001193125-26-326216.md) | [28.8](/filings/0001193125-26-437877.md) | [29.4 d](/filings/0001193125-26-048898.md) | [30.3](/filings/0001193125-26-197581.md) | [30.0](/filings/0001193125-26-326216.md) | [28.8](/filings/0001193125-26-437877.md) |
| Diluted EPS | $ per share | not reported | [0.26](/filings/0000950170-25-061874.md) | [0.27](/filings/0000950170-25-100336.md) | [0.27](/filings/0001193125-25-256338.md) | not reported | [0.26](/filings/0001193125-26-197581.md) | [0.28](/filings/0001193125-26-326216.md) | [0.28](/filings/0001193125-26-437877.md) | not reported | [0.28](/filings/0001193125-26-197581.md) | [0.27](/filings/0001193125-26-326216.md) | [0.26](/filings/0001193125-26-437877.md) |
| Basic EPS | $ per share | not reported | [0.26](/filings/0000950170-25-061874.md) | [0.27](/filings/0000950170-25-100336.md) | [0.27](/filings/0001193125-25-256338.md) | not reported | [0.26](/filings/0001193125-26-197581.md) | [0.28](/filings/0001193125-26-326216.md) | [0.28](/filings/0001193125-26-437877.md) | not reported | [0.28](/filings/0001193125-26-197581.md) | [0.27](/filings/0001193125-26-326216.md) | [0.26](/filings/0001193125-26-437877.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Operating income: not reported
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [16.3](/filings/0001193125-26-048898.md) | [26.1](/filings/0001650132-24-000078.md) | [17.2](/filings/0000950170-24-089412.md) | [44.5](/filings/0000950170-24-119590.md) | [4.1](/filings/0001193125-26-048898.md) | [22.3](/filings/0001193125-26-197581.md) | [6.0](/filings/0001193125-26-326216.md) | [6.7](/filings/0001193125-26-437877.md) | [12.1](/filings/0001193125-26-437877.md) | [29.6](/filings/0001193125-26-197581.md) | [24.8](/filings/0001193125-26-326216.md) | [7.2](/filings/0001193125-26-437877.md) |
| Total assets | $m | [2,452](/filings/0000950170-25-020029.md) | [2,463](/filings/0001650132-24-000078.md) | [2,486](/filings/0000950170-24-089412.md) | [2,564](/filings/0000950170-24-119590.md) | [2,653](/filings/0001193125-26-048898.md) | [2,711](/filings/0000950170-25-061874.md) | [2,766](/filings/0000950170-25-100336.md) | [2,834](/filings/0001193125-25-256338.md) | [2,921](/filings/0001193125-26-437877.md) | [2,952](/filings/0001193125-26-197581.md) | [2,996](/filings/0001193125-26-326216.md) | [3,303](/filings/0001193125-26-437877.md) |
| Total liabilities | $m | [1,192](/filings/0000950170-25-020029.md) | [1,198](/filings/0001650132-24-000078.md) | [1,225](/filings/0000950170-24-089412.md) | [1,210](/filings/0000950170-24-119590.md) | [1,202](/filings/0001193125-26-048898.md) | [1,278](/filings/0000950170-25-061874.md) | [1,283](/filings/0000950170-25-100336.md) | [1,299](/filings/0001193125-25-256338.md) | [1,291](/filings/0001193125-26-437877.md) | [1,288](/filings/0001193125-26-197581.md) | [1,374](/filings/0001193125-26-326216.md) | [1,672](/filings/0001193125-26-437877.md) |
| Long-term debt | $m | [1,113](/filings/0000950170-25-020029.md) | [1,131](/filings/0001650132-24-000078.md) | [1,159](/filings/0000950170-24-089412.md) | [1,132](/filings/0000950170-24-119590.md) | [1,138](/filings/0001193125-26-048898.md) | [1,202](/filings/0000950170-25-061874.md) | [1,203](/filings/0000950170-25-100336.md) | [1,214](/filings/0001193125-25-256338.md) | [1,204](/filings/0001193125-26-437877.md) | [1,205](/filings/0001193125-26-197581.md) | [1,253](/filings/0001193125-26-326216.md) | [1,569](/filings/0001193125-26-437877.md) |
| Shareholders' equity | $m | [1,260](/filings/0001193125-26-048898.md) | [1,264](/filings/0000950170-25-100336.md) | [1,261](/filings/0001193125-25-256338.md) | [1,355](/filings/0001193125-25-256338.md) | [1,451](/filings/0001193125-26-437877.md) | [1,433](/filings/0001193125-26-326216.md) | [1,483](/filings/0001193125-26-437877.md) | [1,536](/filings/0001193125-26-437877.md) | [1,630](/filings/0001193125-26-437877.md) | [1,664](/filings/0001193125-26-326216.md) | [1,622](/filings/0001193125-26-437877.md) | [1,631](/filings/0001193125-26-437877.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [36.4 d](/filings/0001193125-26-048898.md) | [27.6](/filings/0000950170-25-061874.md) | [39.7 d](/filings/0000950170-25-100336.md) | [43.4 d](/filings/0001193125-25-256338.md) | [33.4 d](/filings/0001193125-26-048898.md) | [51.6](/filings/0001193125-26-197581.md) | [43.8 d](/filings/0001193125-26-326216.md) | [48.9 d](/filings/0001193125-26-437877.md) | [48.0 d](/filings/0001193125-26-048898.md) | [47.2](/filings/0001193125-26-197581.md) | [50.7 d](/filings/0001193125-26-326216.md) | [61.1 d](/filings/0001193125-26-437877.md) |
| Capital expenditure | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Dividends paid | $m | [30.7 d](/filings/0001193125-26-048898.md) | [31.5](/filings/0000950170-25-061874.md) | [31.7 d](/filings/0000950170-25-100336.md) | [31.7 d](/filings/0001193125-25-256338.md) | [33.2 d](/filings/0001193125-26-048898.md) | [35.4](/filings/0001193125-26-197581.md) | [35.4 d](/filings/0001193125-26-326216.md) | [36.2 d](/filings/0001193125-26-437877.md) | [37.0 d](/filings/0001193125-26-048898.md) | [39.6](/filings/0001193125-26-197581.md) | [40.1 d](/filings/0001193125-26-326216.md) | [66.9 d](/filings/0001193125-26-437877.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: not reported
- Dividends paid: us-gaap:PaymentsOfDividends

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [86.1](/filings/0001650132-24-000078.md) | [87.6](/filings/0000950170-24-089412.md) | [90.6](/filings/0000950170-24-119590.md) | [91.9](/filings/0000950170-25-061874.md) | [92.0](/filings/0000950170-25-100336.md) | [94.9](/filings/0001193125-25-256338.md) | [100](/filings/0001193125-26-197581.md) | [101](/filings/0001193125-26-326216.md) | [104](/filings/0001193125-26-437877.md) | [110](/filings/0001193125-26-197581.md) | [110](/filings/0001193125-26-326216.md) | [110](/filings/0001193125-26-437877.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 109,756,406 at 2026-10-29, from the cover of the [10-Q filed 2026-10-29](/filings/0001193125-26-437877.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 29, 2026, 18:46 ET. No prices; not investment advice.